Literature DB >> 12736157

Splanchnic free fatty acid kinetics.

Michael D Jensen1, Sylvain Cardin, Dale Edgerton, Alan Cherrington.   

Abstract

These studies were conducted to assess the relationship between visceral adipose tissue free fatty acid (FFA) release and splanchnic FFA release. Steady-state splanchnic bed palmitate ([9,10-(3)H]palmitate) kinetics were determined from 14 sampling intervals from eight dogs with chronic indwelling arterial, portal vein, and hepatic vein catheters. We tested a model designed to predict the proportion of FFAs delivered to the liver from visceral fat by use of hepatic vein data. The model predicted that 15 +/- 2% of hepatic palmitate delivery originated from visceral lipolysis, which was greater (P = 0.004) than the 11 +/- 2% actually observed. There was a good relationship (r(2) = 0.63) between the predicted and observed hepatic palmitate delivery values, but the model overestimated visceral FFA release more at lower than at higher palmitate concentrations. The discrepancy could be due to differential uptake of FFAs arriving from the arterial vs. the portal vein or to release of FFAs in the hepatic circulatory bed. Splanchnic FFA release measured using hepatic vein samples was strongly related to visceral adipose tissue FFA release into the portal vein. This finding suggests that splanchnic FFA release is a good indicator of visceral adipose tissue lipolysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736157     DOI: 10.1152/ajpendo.00268.2002

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  14 in total

Review 1.  Abdominal obesity: a marker of ectopic fat accumulation.

Authors:  Ulf Smith
Journal:  J Clin Invest       Date:  2015-05-01       Impact factor: 14.808

2.  Androgens, body fat Distribution and Adipogenesis.

Authors:  Mouna Zerradi; Julie Dereumetz; Marie-Michèle Boulet; André Tchernof
Journal:  Curr Obes Rep       Date:  2014-12

3.  The Effects of Pathogen-Associated Molecular Patterns on Peripheral Blood Monocytes in Patients with Non-alcoholic Fatty Liver Disease.

Authors:  Qian Li; Julia D Rempel; Jiaqi Yang; Gerald Y Minuk
Journal:  J Clin Exp Hepatol       Date:  2021-11-25

4.  Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population.

Authors:  Maobin Kuang; Song Lu; Qiyang Xie; Nan Peng; Shiming He; Changhui Yu; Jiajun Qiu; Guotai Sheng; Yang Zou
Journal:  BMC Gastroenterol       Date:  2022-06-25       Impact factor: 2.847

Review 5.  Role of body fat distribution and the metabolic complications of obesity.

Authors:  Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

6.  Splanchnic lipolysis in human obesity.

Authors:  Soren Nielsen; ZengKui Guo; C Michael Johnson; Donald D Hensrud; Michael D Jensen
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 7.  Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance.

Authors:  Kimber L Stanhope; Peter J Havel
Journal:  Curr Opin Lipidol       Date:  2008-02       Impact factor: 4.776

8.  Rapid development of systemic insulin resistance with overeating is not accompanied by robust changes in skeletal muscle glucose and lipid metabolism.

Authors:  Andrea S Cornford; Alexander Hinko; Rachael K Nelson; Ariel L Barkan; Jeffrey F Horowitz
Journal:  Appl Physiol Nutr Metab       Date:  2012-11-21       Impact factor: 2.665

9.  Higher plain water intake is related to lower newly diagnosed nonalcoholic fatty liver disease risk: a population-based study.

Authors:  Xing Wang; Shiyu Lin; Shinan Gan; Yeqing Gu; Ying Yang; Qing Zhang; Li Liu; Ge Meng; Zhanxin Yao; Dong Zheng; Hongmei Wu; Shunming Zhang; Yawen Wang; Tingjing Zhang; Shaomei Sun; Qiyu Jia; Kun Song; Xiao-Hui Wu; Yuntang Wu; Kaijun Niu
Journal:  Eur J Clin Nutr       Date:  2021-04-09       Impact factor: 4.016

Review 10.  Fat depots, free fatty acids, and dyslipidemia.

Authors:  Jon O Ebbert; Michael D Jensen
Journal:  Nutrients       Date:  2013-02-07       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.